PUSHPA RAUNIYAR: Open Payments
NPI 1396590469 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 45 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $460 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $161 |
| ABBVIE INC. | 6 | $148 |
| AstraZeneca Pharmaceuticals LP | 6 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $124 |
| PFIZER INC. | 5 | $101 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Seqirus USA Inc | 2 | $60 |
| Lilly USA, LLC | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Bausch Health US, LLC | 3 | $54 |
Products named: REPATHA, AIRSUPRA, VRAYLAR, Kerendia, SHINGRIX, NURTEC ODT, Fluad, REXULTI.
Industry payments across CO — which companies pay providers there.
